ArticlePloS one2013

Early growth response 3 (Egr3) is highly over-expressed in non-relapsing prostate cancer but not in relapsing prostate cancer.

Rebecca Pio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.